Global Payments raised to Buy equivalent at Wolfe Research

Q2 non-GAAP EPS exceeded estimates by $0.02, and revenue increased by 33.9% year-over-year to $3.16B, confirming performance improvement. This served as the basis for Wolfe Research's target price increase to $110; however, with the current stock price at $86.21, there remains approximately 27.6% upside potential. While short-term financial momentum has been confirmed, sustainability remains uncertain.

The upgrade of the investment rating by Wolfe Research and the target price of $110 served as a major catalyst; however, this is an assessment by external analysts and not a business plan controllable by the company itself, making it difficult to consider it a repeatable catalyst. While the improvement in performance is positive, it is based on past data that has already been reflected in evaluations, leading to disappointment over the absence of new internal catalysts to drive future rebounds.